COVID-19

Learn how the University of Manchester leveraged IMO’s robust clinical interface terminology to help drive their COVID-19 shielding algorithm.
Learn about social determinants of health and why they’re key to fighting health disparities resulting from inequity.
IMO’s CMO, Andrew S. Kanter, MD, answers questions on monkeypox and what the health IT industry can do to help clinicians stay
Healthcare providers must screen for and measure SDOH to move towards health equity, but challenges in standardization and alignment lie ahead.
With the easing of COVID-19 restrictions countries are reducing genomic surveillance, limiting the data necessary to prepare for new variants.
Federal legislation aimed at improving the public health response to emergencies like the COVID-19 pandemic gains bipartisan support.
The COVID-19 pandemic exposed longstanding problems in public health. IMO’s Chief Strategy Officer, Dale Sanders, suggests ways to fix an ailing system.
Last year, IMO’s Chief Strategy Officer, Dale Sanders, sat down with HIMSS to talk about COVID-19 data aggregation and management challenges. As
As COVID-19 continues to impact healthcare globally, IMO experts consider what’s in store for health IT in 2022.
With the Omicron variant on everyone’s mind, our latest insight brief explores the science of COVID-19 variants and the complexity of generating
The COVID-19 pandemic has exposed a number of systemic problems hindering healthcare in the United States. Below, IMO’s Chief Medical Officer, Andrew
Clinician burnout is real but just how much is it impacting healthcare? This excerpt from our latest eBook provides a snapshot of